NO996117D0 - Device for administering medications and treating viral and microbial infections and healing syndrome - Google Patents

Device for administering medications and treating viral and microbial infections and healing syndrome

Info

Publication number
NO996117D0
NO996117D0 NO996117A NO996117A NO996117D0 NO 996117 D0 NO996117 D0 NO 996117D0 NO 996117 A NO996117 A NO 996117A NO 996117 A NO996117 A NO 996117A NO 996117 D0 NO996117 D0 NO 996117D0
Authority
NO
Norway
Prior art keywords
healing
syndrome
microbial infections
treating viral
administering medications
Prior art date
Application number
NO996117A
Other languages
Norwegian (no)
Other versions
NO996117L (en
Inventor
Michelle Olga Patricia Visser
Original Assignee
Cryopreservation Tech Cc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Tech Cc filed Critical Cryopreservation Tech Cc
Publication of NO996117D0 publication Critical patent/NO996117D0/en
Publication of NO996117L publication Critical patent/NO996117L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10Sulfides; Sulfoxides; Sulfones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • AIDS & HIV (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO996117A 1997-06-13 1999-12-10 Device for administering medications and treating viral and microbial infections and taering syndrome NO996117L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (2)

Publication Number Publication Date
NO996117D0 true NO996117D0 (en) 1999-12-10
NO996117L NO996117L (en) 2000-02-11

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996117A NO996117L (en) 1997-06-13 1999-12-10 Device for administering medications and treating viral and microbial infections and taering syndrome

Country Status (34)

Country Link
EP (1) EP1011567A1 (en)
JP (1) JP4531141B2 (en)
KR (1) KR20010013709A (en)
CN (1) CN1260703A (en)
AP (1) AP1629A (en)
AR (1) AR012970A1 (en)
AU (1) AU7831598A (en)
BG (1) BG103997A (en)
BR (1) BR9810095A (en)
CA (1) CA2295176A1 (en)
CZ (1) CZ298510B6 (en)
EA (1) EA200000011A1 (en)
EE (1) EE9900562A (en)
ES (1) ES2161187B1 (en)
FI (1) FI19992648A (en)
GB (1) GB2341319B (en)
HU (1) HUP0003034A2 (en)
ID (1) ID23516A (en)
IL (2) IL133396A0 (en)
IS (1) IS5289A (en)
LT (1) LT4714B (en)
LV (1) LV12490B (en)
NO (1) NO996117L (en)
NZ (1) NZ501669A (en)
OA (1) OA11307A (en)
PL (1) PL196256B1 (en)
RO (1) RO121252B1 (en)
SI (1) SI20191A (en)
SK (1) SK172299A3 (en)
TN (1) TNSN98086A1 (en)
TR (1) TR200000540T2 (en)
WO (1) WO1998056325A1 (en)
YU (1) YU66099A (en)
ZA (1) ZA984649B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
WO1993016992A1 (en) * 1992-02-20 1993-09-02 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
NZ330642A (en) * 1995-12-15 2000-06-23 Cryopreservation Tech Cc Transdermal amide composition for organ cryopreservation and vaccine for treating microbial and/or virus infections

Also Published As

Publication number Publication date
LV12490A (en) 2000-06-20
BR9810095A (en) 2001-11-13
YU66099A (en) 2002-10-18
PL338439A1 (en) 2000-11-06
EE9900562A (en) 2000-06-15
NO996117L (en) 2000-02-11
GB9929189D0 (en) 2000-02-02
IS5289A (en) 1999-12-08
AP1629A (en) 2006-07-11
AU7831598A (en) 1998-12-30
JP4531141B2 (en) 2010-08-25
CN1260703A (en) 2000-07-19
GB2341319B (en) 2002-02-27
ES2161187A1 (en) 2001-11-16
SI20191A (en) 2000-10-31
JP2002511862A (en) 2002-04-16
IL133396A0 (en) 2001-04-30
SK172299A3 (en) 2000-09-12
IL133396A (en) 2006-10-05
ES2161187B1 (en) 2003-08-16
ZA984649B (en) 1999-12-17
AR012970A1 (en) 2000-11-22
KR20010013709A (en) 2001-02-26
EA200000011A1 (en) 2000-08-28
FI19992648A (en) 2000-02-03
TR200000540T2 (en) 2000-09-21
HUP0003034A2 (en) 2000-12-28
CA2295176A1 (en) 1998-12-17
TNSN98086A1 (en) 2005-03-15
EP1011567A4 (en) 2000-06-28
AP9901708A0 (en) 1999-12-31
GB2341319A (en) 2000-03-15
LT99148A (en) 2000-07-25
PL196256B1 (en) 2007-12-31
OA11307A (en) 2003-10-24
RO121252B1 (en) 2007-02-28
CZ9904473A3 (en) 2001-03-14
WO1998056325A1 (en) 1998-12-17
LT4714B (en) 2000-10-25
NZ501669A (en) 2001-09-28
LV12490B (en) 2000-12-20
ID23516A (en) 2000-04-27
EP1011567A1 (en) 2000-06-28
CZ298510B6 (en) 2007-10-24
BG103997A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
DE69401549D1 (en) Plasma treatment device
NO991700D0 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
KR960702328A (en) Medical Device with Infection Preventing Feature
DE60019490D1 (en) Fuel conveyor and treatment device
DE69620381T2 (en) GAME DEVICE AND SYSTEM THEREFOR
DE69218793T2 (en) GAME DEVICE AND GAME SYSTEM
EE9800042A (en) Device used in inhalers
DE69823583D1 (en) Cassette and cassette delivery system
DE69719108D1 (en) Plasma treatment device
DE9410974U1 (en) Air treatment device
BR9607851B1 (en) combination and pharmaceutical formulation.
DE68905374D1 (en) AGENT FOR PREVENTING AND REMEDYING ISCHAEMIC INJURIES.
EE9600139A (en) Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions
DK91793D0 (en) PROCEDURE FOR SURFACE TREATMENT, MEDICINES FOR EXERCISE AND APPLICATION
NO996117D0 (en) Device for administering medications and treating viral and microbial infections and healing syndrome
DE29506176U1 (en) Disc-shaped treatment device
DE9314448U1 (en) Ultraviolet treatment device
KR970020622U (en) Thinkstand with sterilization and drying device
BR9400411A (en) Medication for the treatment of lacerations, trauma, adverse infections and asepsis
DE29801793U1 (en) Therapy and treatment device
DE29600892U1 (en) Medicine bottle
ES1023597Y (en) PERFECTED THERAPEUTIC BANDAGE.
DE9314593U1 (en) Medical treatment card
KR940027375U (en) Curing treatment device
KR960009678U (en) Up and down type medicine spraying device

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application